(Q36454251)

14 August 2017

1 reference

title

The pharmacokinetics of azithromycin and their clinical significance (English)

1 reference

14 August 2017

0 references

1 reference

Lode H

1

1 reference

14 August 2017

1 October 1991

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

14 August 2017

1 reference

14 August 2017

10

1 reference

14 August 2017

10

1 reference

14 August 2017

807-812

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01975832

14 August 2017

0 references

cites work

Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms

1 reference

https://api.crossref.org/works/10.1007%2FBF01975832

Efficacy of azithromycin in the treatment of guinea pigs infected with Legionella pneumophila by aerosol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975832

In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975832

Commentary. Lysosomotropic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975832

Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975832

Correlation of the extravascular pharmacokinetics of azithromycin with in-vivo efficacy in models of localized infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975832

Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975832

Bacteriostatic and bactericidal activity of azithromycin against Haemophilus influenzae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975832

Comparative in-vitro activity of azithromycin and erythromycin against Gram-positive cocci, Haemophilus influenzae and anaerobes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975832

Azithromycin in the treatment of sexually transmitted disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975832

Concentrations of azithromycin in human tonsillar tissue

21 January 2018

1 reference

12 December 2020

Synthesis, in vitro and in vivo activity of novel 9-deoxo-9a-AZA-9a-homoerythromycin A derivatives; a new class of macrolide antibiotics, the azalides

1 reference

12 December 2020

Comparison of the acid stability of azithromycin and erythromycin A

1 reference

12 December 2020

Relationship of high tissue concentrations of azithromycin to bactericidal activity and efficacy in vivo

1 reference

12 December 2020

The pharmacokinetics and inflammatory fluid penetration of orally administered azithromycin

1 reference

12 December 2020

Tissue penetration of erythromycin (author's transl)

1 reference

12 December 2020

The pharmacokinetics of azithromycin in human serum and tissues

1 reference

12 December 2020

The in-vitro activity of CP-62,993 against Haemophilus influenzae, Branhamella catarrhalis, staphylococci and streptococci

1 reference

12 December 2020

Pharmacokinetics of azithromycin in rats and dogs

1 reference

12 December 2020

Azithromycin concentrations at the sites of pulmonary infection

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01975832

1 reference

14 August 2017

1 reference

PubMed ID

1662623